Diabetic Macular Edema
Diffuse diabetic macular edema is improved by intravitreal injection of triamcinolone
Published in Obesity and Diabetes Week, October 30th, 2006
Investigators in France conducted a study "to evaluate prospectively the efficacy and safety of one intravitreal injection of 4 mg triamcinolone acetonide for refractory diffuse diabetic macular edema."
"Seventeen patients with bilateral diabetic macular edema unresponsive to laser photocoagulation. In all patients, one eye was injected, and the other served as a control. The intervention consisted in intravitreal injection of 4 mg triamcinolone acetonide. The main outcome measure was central macular thickness (CMT) at 4, 12 and 24...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
More Articles from Obesity and Diabetes Week
- Adipocyte
In rat adipocytes, AICAR-induced AMPK phosphorylation inhibits insulin-stimulated glucose uptake - Diet & Nutrition
Hydroxycitrate attenuates body weight and visceral fat, but leads to accumulation of liver lipids - Obesity Complications
Conjugated linoleic acids do not affect lipoprotein profile in overweight with LDL phenotype B - Obesity Epidemiology
Meal size, not body size, explains errors in estimating the calorie content of meals - Renal Function
Obese hypertensives lose renal reserve earlier in renal dysfunction evolution - Obesity and Diabetes
Center for Molecular and Vascular Biology describes research in obesity and diabetes - More from this issue of Obesity and Diabetes Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
